Intellia Therapeutics has named Caroline Dorsa to its board of directors. Dorsa brings over 30 years of management experience in the energy, pharmaceuticals, and telecommunications industries.
Dorsa has previously held positions at Merck, where she was VP and Treasurer. Most recently, she was exectuive VP and CFO at the Public Service Enterprise Group. Dorsa also serves on the board of Biogen.